Stardust Intelligence Raises $200M Series B, Valuation Exceeds $1 Billion
## Stardust Intelligence: From Tsinghua Lab to Billion-Dollar Unicorn
Stardust Intelligence, founded in 2023 and incubated at Tsinghua University, has emerged as one of China's most promising humanoid robotics companies. The company's recent $200 million Series B funding round has pushed its valuation past the billion-dollar threshold, marking a significant milestone in the embodied AI race.
### Commercial Deployment at Scale
What sets Stardust apart is its rapid path from lab to commercial deployment. The company has deployed its STAR1 humanoid robots across:
- **10+ logistics centers** operated by China Post and SF Express - Coverage spanning northern, eastern, and southern China - **85% of human-level efficiency** achieved - **24/7 continuous operation** capability
In Q2 2026, the company initiated batch deliveries at the thousand-robot scale, reporting a remarkable **300% growth rate**.
### Strategic Investors
The funding round was led by SF Express, China's largest private logistics operator, with participation from: - Sequoia China - IDG Capital - Multiple institutional heavyweights
SF Express's strategic involvement signals strong industrial demand for humanoid solutions in logistics operations.
### Technology Stack
Stardust Intelligence has developed a full-stack AI capability:
- **ERA-42**: Proprietary AI model - **World Model**: For environment understanding - **STAR1 Robot**: Full-scale humanoid platform
## Key Metrics
| Metric | Value | |--------|-------| | Series B Amount | $200M | | Valuation | >$1B | | Logistics Centers | 10+ | | Efficiency vs Human | 85% | | Q2 Growth Rate | 300% |
## Industry Context
Stardust's success reflects the broader momentum in China's embodied AI sector. According to industry data, the sector recorded 610 investment deals totaling approximately $7 billion in the first nine months of 2025 alone - a 250% increase year-over-year.
With over 10 embodied AI companies now valued above CNY 10 billion, 2026 is shaping up as the critical year for validating whether this unicorn cohort can deliver real commercial value at scale.
